Jiangsu Aogu Biotechnology Co., Ltd.
AboutAogu
Jiangsu Aogu Biotechnology Co., Ltd. was founded in 2008 and is headquartered in Liyang, Jiangsu Province. The company primarily engages in the research and development of bioenzyme preparations and the bioenzymatic production of functional sugars, which serve as food ingredients or additives to replace white sugar in low-sugar and sugar-free foods and beverages. It also utilizes synthetic biotechnology to produce feed-grade amino acids, pharmaceutical-grade amino acids, nucleotides, and other products for use as pharmaceutical raw materials, pharmaceutical intermediates, nutritional supplements, and animal nutrition products. Currently, the company operates five major production bases in Liyang, Jiangsu, and Songyuan, Jilin, with an annual production capacity of 100,000 metric tons of trehalose and blended sweeteners, 20,000 metric tons of complex sugars, 8,000 metric tons of β-cyclodextrin, 10,000 metric tons of polydextrose, 20,000 metric tons of feed-grade amino acids, 300 metric tons of nicotinamide mononucleotide (NMN), glutathione, and gamma-aminobutyric acid, and 1,500 metric tons of pharmaceutical-grade amino acids.
Engaged in the research and development of biological enzyme preparations.
Jiangsu Aogu Biotechnology Co., Ltd. (“Jiangsu Aogu”) was established in 2008 and is headquartered in Liyang, Jiangsu Province.
Trehalose/β-cyclodextrin/NMN
Enterprises capable of producing over 90% maltose powder and trehalose syrup
Company employees
The company’s R&D team comprises more than 50 members, with the core team graduating from Tsinghua University and Jiangnan University.
The company holds patent applications.
Awarded the honors of Jiangsu Provincial Enterprise Technology Center, Jiangsu Provincial Engineering Technology Research Center, Jiangsu Provincial Specialized, Sophisticated and Novel SME, Jilin Provincial Specialized, Sophisticated and Novel Enterprise, and Songyuan City Key Leading Agricultural Enterprise.
We offer six comprehensive support systems to help you eliminate the day-to-day hassles of entrepreneurship and focus on your core business.
EmpoweringPlatform enterprises
Amid the wave of innovation and transformation sweeping the manufacturing sector, Jiangsu Aogu Biotechnology Co., Ltd. has adopted a core guiding principle: “Provide opportunities for those who are eager to act, reward those who deliver results, and ensure the sustainability of successful ventures.” To this end, the company has built a platform-based corporate ecosystem featuring “business partners + dual platforms + business units,” thereby breaking down traditional organizational boundaries and unleashing the creative potential of every individual. We firmly believe that outstanding enterprises are not control-oriented organizations but empowering platforms. Through the “business partner” mechanism, we have eliminated hierarchical constraints, enabling individuals who share the company’s vision and possess an entrepreneurial spirit to both seize growth opportunities and assume shared responsibility for the enterprise. This approach deeply aligns personal development with corporate growth, providing a broad stage for those who are truly committed to making things happen.
View DetailsService Platform
Provide seed funding support and facilitate access to diversified financing channels.
Support for strategic planning, organizational development, and talent system building
Specialized services such as financial accounting, safety and environmental protection, and equipment maintenance
What has remained unchanged over the years is our unwavering commitment to the quality of our products and services.
EnterpriseHistory of Development
Service Platform
2008–2011
Company Establishment
2012–2015
Extending downstream to break the international technology monopoly, trehalose has achieved mass production.
2016–2019
Multi-product development and market development for trehalose applications
2020
Establish a major production base in Northeast China Establish a synthetic biology pilot-scale demonstration base in Liyang
2021
Trehalose Phase I production commences, NMN plant commissioned, cyclodextrin capacity expanded.
2022
Trehalose Phase II goes into production; new polydextrose project is constructed and commissioned.
2023
Trehalose Phase III comes on stream; amino acid production line is renovated and commissioned.
2024
Construction and commissioning of the Phase I 200,000-ton trehalose and compound formulation project in Fujin
Focused on R&D and innovation in synthetic biology
Comprehensive industrial layout
Supporting China’s Industrial Biomanufacturing
Supporting the development of green food and safeguarding human health and stability
ProductIntroduction
Possessing core proprietary technologies, we continuously build momentum for the future.
NewsInformation
The platform is ready—now it’s up to you to take the stage.
Join us,Define Your Own Career
WELCOME TO JOIN
We believe that the best kind of entrepreneurship isn’t about going it alone—it’s about growing together within an empowering ecosystem. Here, you’re not an “employee”; you’re a “business partner.” You’re not an “executor”; you’re an “entrepreneur.” The platform is in place, and the resources are ready—all that’s missing is the star player: you, with your entrepreneurial dreams and unique assets.
0519-87171088